General Psychiatry - Articles - Page 7

MDMA: What Went Wrong Part 1

June 10, 2024

Did boundary violations sink MDMA assisted psychotherapy? We explore the reasons behind the FDA panel’s rejection of this psychedelic therapy.

CARLAT WEBINAR

Carlat Psychiatry News - Episode 2 - TMS for Teens

June 1, 2024

Chris Aiken, MD, Greg Malzberg, MD, and Kellie Newsome, PMHNP

0.25 CME Credits. Psychiatric news covered in this episode: TMS for Teens, Olanzapine Serum Levels, Old Medication Pairing Emerges for Novel Alcoholism Treatment, Old Medication Pairing Emerges for Novel Alcoholism Treatment, Promising Option For Transitioning Insomnia Medications, Lithium's Anti-Suicide Effects in Question, Role of Omega-3 Supplements in Psychosis Risk Reduction, Caffeine and Anxiety: A Concerning Connection for Coffee Lovers.

CME Post-Test, Combined Psychotherapy & Psychopharmacology, TCPR, June/July 2024

June 1, 2024

By successfully completing the test you will be awarded a certificate for 2 CME credit.

Research Update

Does Haloperidol Improve Hospitalization or Mortality in Delirium?

June 1, 2024

Jeremy Mills, DNP, PMHNP-BC

Jeremy Mills, DNP, PMHNP-BC. Dr. Mills has no financial relationships with companies related to this material.

Another trial questions the benefits of antipsychotics in delirium.

Research Update

Memantine for Trichotillomania and Excoriation Disorder

June 1, 2024

Sarah Azarchi, MD

Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.

New analysis questions whether STAR*D followed its own protocols.

Research Update

STAR*D Reanalysis Causes New Debate Over Antidepressant Efficacy

June 1, 2024

Alex Evans, PharmD, MBA.

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

New analysis questions whether STAR*D followed its own protocols.

Expert Q&A

Ketamine-Assisted Therapy

June 1, 2024

Kyle T. Greenway, MD, MSc

Kyle T. Greenway, MD, MSc.

Assistant Professor of Psychiatry at McGill University. Director of the ketamine-assisted therapy program at Jewish General Hospital, Montreal, Canada.

Dr. Greenway has no financial relationships with companies related to this material.

A psychotherapeutic plan to make ketamine’s benefits last.

Expert Q&A

How to Incorporate Psychodynamic Principles Into Your Practice

June 1, 2024

David Mintz, MD

David Mintz, MD.

Fellow, American Academy of Psychoanalysis and Dynamic Psychiatry. Staff psychiatrist, Austen Riggs Center, Stockbridge, MA.

Dr. Mintz has no financial relationships with companies related to this material.

Practical psychodynamics enhance pharmacotherapy with treatment-resistant cases: Here’s how to foster patient agency and readiness for change.

Clinical Update

Off-Label Strategies for Common Psychiatric Conditions

June 1, 2024

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Five disorders where going off-label has advantages over the FDA-approved route.